Skip to main content

Search Results

Displaying: 1 - 10 of 15 Results

Utilizing the herpes simplex virus-based vaccine vectors to develop a COVID-19 vaccine

Researchers in the lab of David Knipe have constructed the HSV-1 based vaccine vector HSV-1 d106S. The vector can express viral, bacterial, or cancer gene products has been used to induce protective immunity in humanized mice against HIV and rhesus…

Investigators

  • David Knipe

Novel adjuvants to enhance adaptive immune response of vaccines

Researchers in the lab of Ulrich von Andrian have discovered a novel adjuvanting behavior of a clinically approved and well-tolerated class of medicines known as bisphosphonates. The team is hoping to collaborate with manufacturers of COVID-19…

Investigators

  • Ulrich von Andrian

Self-adjuvanting mRNA platform technology

Researchers in the lab of Prof. George Church at Harvard Medical School have developed a vaccine platform technology that can be applied to fields such as infectious diseases and oncology therapeutics. The team is looking to further demonstrate…

Investigators

  • George Church

Evolution of Sequence-Defined Highly Functionalized Nucleic Acid Polymers

DESCRIPTION Template-directed synthesis of modified DNA sequences can provide a rich source of material for generating new therapies featuring modified nucleic acid polymers. The Liu lab has previously developed pioneering methods to generate…

Investigators

  • David Liu

CD1- mice developed in the laboratory of Dr. Michael Grusby

Homozygous Cd1tm1Gru knock-out mice (C.129S2-Cd1tm1Gru/J, also known as CD1-) were developed by Dr. Michael J. Grusby at Harvard University. The mutant mice are deficient in both the Cd1.1 and Cd1.2 genes, and lack the normal natural killer…

Investigators

  • Michael Grusby

A system for in vivo generation of protective CD8+ T lymphocytes and other cells of hematopoietic origin

Differentiated CD8+ effector T cells mediate long-term immunity and protection against infectious diseases and cancer. Naive T cells are refractory to transduction with viral vectors without extensive ex vivo manipulations. A team of researchers at…

Investigators

  • Arlene Sharpe
  • Nicholas Haining

Microbiome reagents to treat inflammatory bowel disease and restore gut homeostasis

Reactive oxygen species (ROS) and oxidative stress are believed to cause and/or aggravate several diseases, including inflammatory diseases like inflammatory bowel disease (IBD). Antioxidants have the ability to neutralize the damaging effects of…

Investigators

  • Wendy Garrett

Immunology and Computational Biology Partnership

Professors Diane Mathis and Christophe Benoist at Harvard Medical School, together with other world-renowned immunologists and computational biologists from multiple research institutions, have created the Immunological Genome Project – Immgen…

Investigators

  • Diane Mathis
  • Christophe Benoist

Migration inhibitory factor (MIF) knockout mouse

To study the biological role of migration inhibitory factor (MIF), a pleiotropic cytokine, we generated a mouse strain lacking MIF by gene targeting in embryonic stem cells. Analysis of the role of MIF during sepsis showed that MIF-/- mice were…

Investigators

  • John David
  • Marcelo Bozza
  • Craig Gerard

Novel peptide therapeutic for multiple sclerosis

In multiple sclerosis, the host's immune system (lead by T-cells) attacks and destroys myelin basic protein, the principle component necessary for nerve transmission. Part and parcel of this immune response pathway are the so-called Major…

Investigators

  • Jack Strominger
  • Masha Fridkis-Hareli

Page 1 of 2